Brain infusion upgrade: could a new method make Parkinson's treatment easier?

NCT ID NCT07215403

Not yet recruiting Disease control Sponsor: AskBio Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times

Summary

This study tests a new, faster method to deliver the drug AB-1005 into the brain of people with advanced Parkinson's disease. The goal is to see if the new approach can consistently reach the target area while being safer and quicker. 18 participants will be enrolled to assess the procedure's accuracy and safety over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AB-1005 (a drug delivered directly into the brain)
What this could lead to: If successful, this could make brain infusions for Parkinson's quicker and more reliable, potentially improving treatment delivery.
What could go wrong: This is a small, early-stage trial focused on the delivery method, not on whether the drug itself works. The procedure still carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE (DISORDER)

Contacts and locations

Locations

Medical University of South Carolina

Charleston, South Carolina, 29425, United States
The Ohio State University Wexner Medical Center Neurological Surgery

Columbus, Ohio, 43210, United States
University Hospitals Cleveland Medical Center

Cleveland, Ohio, 44106, United States
University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.